DK1053018T3 - Administration af immunogene molekyler via HBsAg-partikler - Google Patents
Administration af immunogene molekyler via HBsAg-partiklerInfo
- Publication number
- DK1053018T3 DK1053018T3 DK99902800T DK99902800T DK1053018T3 DK 1053018 T3 DK1053018 T3 DK 1053018T3 DK 99902800 T DK99902800 T DK 99902800T DK 99902800 T DK99902800 T DK 99902800T DK 1053018 T3 DK1053018 T3 DK 1053018T3
- Authority
- DK
- Denmark
- Prior art keywords
- hbsag particles
- administration
- particles
- molecules via
- immunogenic molecules
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 230000002163 immunogen Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000004044 response Effects 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 230000000763 evoking effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7347698P | 1998-02-03 | 1998-02-03 | |
| PCT/IL1999/000060 WO1999039736A2 (en) | 1998-02-03 | 1999-01-29 | DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1053018T3 true DK1053018T3 (da) | 2005-08-15 |
Family
ID=22113916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99902800T DK1053018T3 (da) | 1998-02-03 | 1999-01-29 | Administration af immunogene molekyler via HBsAg-partikler |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1053018B1 (enExample) |
| JP (1) | JP4480267B2 (enExample) |
| AT (1) | ATE300312T1 (enExample) |
| AU (1) | AU755957B2 (enExample) |
| CA (1) | CA2319599C (enExample) |
| DE (1) | DE69926342T2 (enExample) |
| DK (1) | DK1053018T3 (enExample) |
| ES (1) | ES2242376T3 (enExample) |
| WO (1) | WO1999039736A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ912000A0 (en) * | 2000-07-31 | 2000-08-24 | Crown In The Right Of The Queensland Department Of Health, The | Improved virus like particles |
| DE10106235A1 (de) * | 2001-02-10 | 2002-08-22 | Bosch Gmbh Robert | Wischarm |
| KR20060015534A (ko) | 2003-04-25 | 2006-02-17 | 더 펜 스테이트 리서치 파운데이션 | 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템 |
| CU23405A1 (es) * | 2003-10-20 | 2009-08-04 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas para uso terapéutico |
| PL1802746T3 (pl) | 2004-10-27 | 2011-10-31 | Crucell Switzerland Ag | Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B |
| JP2009120532A (ja) * | 2007-11-14 | 2009-06-04 | Osaka Univ | 糖及び糖鎖認識機構を利用する物質送達用及びバイオイメージング用バイオナノカプセル |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5039522A (en) * | 1988-01-29 | 1991-08-13 | New York Blood Center, Inc. | Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen |
| JP2001526688A (ja) * | 1997-05-19 | 2001-12-18 | メルク エンド カンパニー インコーポレーテッド | オリゴヌクレオチドアジュバント |
-
1999
- 1999-01-29 DE DE69926342T patent/DE69926342T2/de not_active Expired - Lifetime
- 1999-01-29 CA CA2319599A patent/CA2319599C/en not_active Expired - Fee Related
- 1999-01-29 JP JP2000530233A patent/JP4480267B2/ja not_active Expired - Fee Related
- 1999-01-29 EP EP99902800A patent/EP1053018B1/en not_active Expired - Lifetime
- 1999-01-29 WO PCT/IL1999/000060 patent/WO1999039736A2/en not_active Ceased
- 1999-01-29 AT AT99902800T patent/ATE300312T1/de not_active IP Right Cessation
- 1999-01-29 ES ES99902800T patent/ES2242376T3/es not_active Expired - Lifetime
- 1999-01-29 AU AU22973/99A patent/AU755957B2/en not_active Ceased
- 1999-01-29 DK DK99902800T patent/DK1053018T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JP4480267B2 (ja) | 2010-06-16 |
| EP1053018B1 (en) | 2005-07-27 |
| WO1999039736A2 (en) | 1999-08-12 |
| AU755957B2 (en) | 2003-01-02 |
| CA2319599A1 (en) | 1999-08-12 |
| ES2242376T3 (es) | 2005-11-01 |
| AU2297399A (en) | 1999-08-23 |
| WO1999039736A3 (en) | 1999-09-23 |
| DE69926342D1 (de) | 2005-09-01 |
| DE69926342T2 (de) | 2006-01-12 |
| ATE300312T1 (de) | 2005-08-15 |
| JP2002502828A (ja) | 2002-01-29 |
| CA2319599C (en) | 2011-04-19 |
| EP1053018A2 (en) | 2000-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0757717A4 (en) | PAPILLOMAVIRUS VACCINE | |
| DE69936386D1 (de) | Sprühgetrocknete proteinformulierungen | |
| ATE377076T1 (de) | Humanes cytokin als ligand des zalpha rezeptors und dessen verwendungen | |
| AU4306896A (en) | Method for the preparation of a viral vector by intermolecular homologous recombination | |
| DK1459766T3 (da) | Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner | |
| DE60043708D1 (de) | Verfahren zur erhaltung zellimmuneantworten gegen proteinen | |
| GEP20002180B (en) | Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation | |
| DE69417252D1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
| CA2231603A1 (en) | Chicken interleukin-15 and uses thereof | |
| BR9811475A (pt) | Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae | |
| SE8303211D0 (sv) | Rena teichomycin a?712 singelfaktorer 1,2,3,4 och 5 och sett for deras framstellning | |
| ES2103311T3 (es) | Compuestos heterociclicos. | |
| DE69926342D1 (de) | Lieferung von immunogenen molekülen unter verwendung von hbsag partikeln | |
| ATE515258T1 (de) | Mukosales verabreichungssytem | |
| NZ515322A (en) | Adjuvant combination formulations | |
| TW200504216A (en) | Immunization of fish with plant-expressed recombinant proteins | |
| ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
| WO2003093298A3 (en) | Immunogenic peptides | |
| MY127452A (en) | Vaccines. | |
| AU1227700A (en) | Method for the production of purified invasin protein and use thereof | |
| DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| PT858345E (pt) | Uso de muteinas de citocinas do tipo selvagem como imunogenios | |
| EP0745386A4 (en) | SECRETORIC RECOMBINANT BCG VACCINE AGAINST AIDS | |
| ATE355078T1 (de) | Untereiheitsimpfstoffe und verfahren zur deren herstellung |